When parents stop a medication they need or interrupt breastfeeding earlier than intended, the impact affects both mother and child. We need better evidence and decision support.
Articles on pharmacovigilance
Displaying all articles
Health Canada continues to monitor newly approved drugs to determine if the benefits identified in the pre-market trials hold up to further scrutiny. Canadians need better access to that information.
Being able to tell the difference between good quality medicines and fakes can be a matter of life and death.
Top contributors
-
Research Platform Chair for Pharmaceutical and Biotech Advancement in Africa (PBA2), Tshwane University of Technology
-
Associate professor, Department of Family and Community Medicine, University of Toronto; York University, Canada; University of Sydney
-
Associate Professor, College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba